Market Tracker

10/23 11:08am ET
8.40
Real-Time Quote
 +0.18 / +2.19%
Today’s Change
7.32
Today|||52-Week Range
11.64
-0.47%
Year-to-Date

Today’s Trading

Previous close8.22
Today’s open8.27
Day’s range8.23 - 8.39
Volume489,358
Average volume (3 months)2,256,947
Market cap$3.5B
Dividend yield--
Data as of 10:53am ET, 10/23/2014

Growth & Valuation

Earnings growth (last year)-190.91%
Earnings growth (this year)+0.78%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+105.19%
P/E ratioNM
Price/Sales31.05
Price/Book3.87

Competitors

 Today’s
change
Today’s
% change
NPSPNPS Pharmaceuticals ...+0.74+2.68%
GRFSGrifols SA+0.50+1.51%
SGENSeattle Genetics Inc+1.29+3.70%
MYGNMyriad Genetics Inc+0.70+1.86%
Data as of 11:08am ET, 10/23/2014

Financials

Next reporting dateNovember 11, 2014
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$96.5M
Annual profit (last year)-$114.4M
Net profit margin-118.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Phillip Frost
Chief Financial Officer, Treasurer, CAO &
SVP
Adam E. Logal
Corporate headquarters
Miami, Florida

Forecasts